{"transactions":[{"id":2672599,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T21:02:16.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":42223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on the one-year anniversary of the date of grant."}],"balance_after":42223,"derivative":{"exercise_price":5.97,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":42223},"source":{"system":"sec-edgar","filing":"0000899243-21-023422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000089924321023422/doc4.xml","form_type":"4"}},{"id":3120967,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-05T16:50:46.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":40138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":40138,"derivative":{"exercise_price":6.48,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":40138},"source":{"system":"sec-edgar","filing":"0000899243-20-015483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000089924320015483/doc4.xml","form_type":"4"}},{"id":3433488,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T21:49:56.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":20000,"price":5.97,"value":119400.0,"ownership":{"direct":false,"nature":"By wife"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $6.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person disclaims beneficial ownership of such shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-19-022160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000089924319022160/doc4.xml","form_type":"4"}},{"id":3433487,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T21:49:56.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":20000,"price":5.7,"value":114000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $5.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":33439,"source":{"system":"sec-edgar","filing":"0000899243-19-022160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000089924319022160/doc4.xml","form_type":"4"}},{"id":3443877,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2019-08-08T16:23:15.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":187500,"price":4,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased as Units, each Unit consisting of one share of Common Stock and a Warrant to purchase 0.75 of one share of Common Stock, at a purchase price of $4.00 per Unit."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":187500,"derivative":{"exercise_price":4.4,"exercise_date":"2019-08-06","expiration_date":"2024-08-06","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000904454-19-000600","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445419000600/edgar.xml","form_type":"4"}},{"id":3443876,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-08T16:23:15.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":250000,"price":4,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased as Units, each Unit consisting of one share of Common Stock and a Warrant to purchase 0.75 of one share of Common Stock, at a purchase price of $4.00 per Unit."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported ownership reflects the one-for-ten reverse split of the Common Stock effected on July 24, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"As managing members of One Palmer Square Associates VII, LLC, which is also the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 4,957 shares of Common Stock held by DP VII Associates, L.P."}],"balance_after":813433,"source":{"system":"sec-edgar","filing":"0000904454-19-000600","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445419000600/edgar.xml","form_type":"4"}},{"id":3496132,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-10T16:46:38.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":28882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over 12 months in equal monthly installments on each monthly anniversary of the date of grant, beginning on 07/06/2019 and ending on 6/06/2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":28882,"derivative":{"exercise_price":14.66,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":28882},"source":{"system":"sec-edgar","filing":"0000904454-19-000484","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000484/edgar.xml","form_type":"4"}},{"id":3532116,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T19:40:10.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the one-year anniversary of the date of grant or the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":0.5834,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000904454-19-000386","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000386/edgar.xml","form_type":"4"}},{"id":3591175,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:53:14.000Z","date":"2019-03-18","kind":"other","acquired":true,"shares":522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."}],"balance_after":13439,"source":{"system":"sec-edgar","filing":"0000904454-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000331/edgar.xml","form_type":"4"}},{"id":3591174,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:53:14.000Z","date":"2019-03-18","kind":"other","acquired":true,"shares":701,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Susan W. and James C. Blair Family L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":10105,"source":{"system":"sec-edgar","filing":"0000904454-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000331/edgar.xml","form_type":"4"}},{"id":3591173,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:53:14.000Z","date":"2019-03-18","kind":"other","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By One Palmer Square Associates VII, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of DP VII Associates, L.P.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000331/edgar.xml","form_type":"4"}},{"id":3591172,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:53:14.000Z","date":"2019-03-14","kind":"sale","acquired":false,"shares":17056,"price":27.79,"value":473986.24,"ownership":{"direct":false,"nature":"By DP VII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.67 to $27.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of DP VII Associates, L.P.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000331/edgar.xml","form_type":"4"}},{"id":3675249,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-05T16:46:42.000Z","date":"2019-02-01","kind":"other","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By One Palmer Square Associates VII, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution-in-kind of shares by Domain Partners VII, L.P. pro rata to its partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution-in-kind of shares by Domain Partners VII, L.P. pro rata to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000904454-19-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000158/edgar.xml","form_type":"4"}},{"id":3675248,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-05T16:46:42.000Z","date":"2019-02-01","kind":"other","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Domain Partners VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution-in-kind of shares by Domain Partners VII, L.P. pro rata to its partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution-in-kind of shares by Domain Partners VII, L.P. pro rata to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-19-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445419000158/edgar.xml","form_type":"4"}},{"id":3791265,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-10-15T16:19:52.000Z","date":"2018-10-11","kind":"grant","acquired":true,"shares":14770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over 12 months in equal monthly installments on each monthly anniversary of the date of grant, beginning on 11/11/2018 and ending on 10/11/2019."}],"balance_after":14770,"derivative":{"exercise_price":27.92,"expiration_date":"2028-10-11","underlying":"Common Stock","underlying_shares":14770},"source":{"system":"sec-edgar","filing":"0000904454-18-000657","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445418000657/edgar.xml","form_type":"4"}},{"id":3833141,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:32:26.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":1648359,"price":1.82,"value":3000013.38,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of One Palmer Square Associates VII, LLC, which is also the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 49,908 shares of Common Stock held by DP VII Associates, L.P."}],"balance_after":5634329,"source":{"system":"sec-edgar","filing":"0000904454-18-000526","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000526/edgar.xml","form_type":"4"}},{"id":3833140,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"price":0,"reported_value":11048,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":4.59,"underlying":"Common Stock","underlying_shares":2505},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833139,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":27328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833138,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":47460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833137,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":40268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":941},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833136,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":22161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":518},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833135,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":50532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1180},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833134,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":2505,"price":4.59,"value":11497.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":6891,"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833133,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":4386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":4386,"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833125,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":15000,"derivative":{"exercise_price":6.125,"exercise_date":"2018-09-20","expiration_date":"2023-09-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833124,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"price":0,"reported_value":1488952,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":4.59,"underlying":"Common Stock","underlying_shares":337694},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833123,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":3682919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":86050},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833122,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":6396105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149441},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833121,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":5426808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":126794},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833120,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":2986762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":69784},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833119,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":6810098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":159115},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833118,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":15000,"price":6.125,"value":91875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":943878,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833117,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":337694,"price":4.59,"value":1550015.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":929878,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833116,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":591184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":591184,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3920943,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-23T16:40:14.000Z","date":"2018-05-21","kind":"other","acquired":true,"shares":5897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares by Domain Associates, LLC to its members, a former member and an employee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares by Domain Associates, LLC to its members, a former member and an employee."}],"balance_after":12917,"source":{"system":"sec-edgar","filing":"0000904454-18-000370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445418000370/edgar.xml","form_type":"4"}},{"id":3920942,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-23T16:40:14.000Z","date":"2018-05-21","kind":"other","acquired":false,"shares":32760,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Domain Associates, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares by Domain Associates, LLC to its members, a former member and an employee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares by Domain Associates, LLC to its members, a former member and an employee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of Domain Associates, LLC, and of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-18-000370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445418000370/edgar.xml","form_type":"4"}},{"id":3928940,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T17:15:39.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the one-year anniversary of the date of grant or the Issuer's 2019 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-05-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000904454-18-000360","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445418000360/edgar.xml","form_type":"4"}},{"id":4125374,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions.  The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions.  The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Redeemable Convertible Preferred Stock had a stated value of $100 (the \"Stated Value\") and accrued dividends daily at an initial rate of 12% per annum, which was reduced to 8% per annum on October 28, 2017 in accordance with the Certificate of Designations for the Redeemable Convertible Preferred Stock. The Stated Value, as adjusted to give effect to such dividends, was referred to as the \"Accrued Value.\" Each share of Redeemable Convertible Preferred Stock was convertible, at the option of the holder or, upon the occurrence of certain events, at the option of the Issuer, and subject to certain conditions, into a number of shares of Common Stock determined by dividing the Accrued Value by the conversion price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":12444},"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125373,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":282,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person received an additional 282 shares of Common Stock from the Issuer, representing the additional dividend accruals on the Redeemable Convertible Preferred Stock that the Reporting Person would have been entitled to receive up to and including March 31, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":25730,"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125372,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":12444,"price":3.19,"value":39696.36,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":25448,"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125371,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":49632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Redeemable Convertible Preferred Stock had a stated value of $100 (the \"Stated Value\") and accrued dividends daily at an initial rate of 12% per annum, which was reduced to 8% per annum on October 28, 2017 in accordance with the Certificate of Designations for the Redeemable Convertible Preferred Stock. The Stated Value, as adjusted to give effect to such dividends, was referred to as the \"Accrued Value.\" Each share of Redeemable Convertible Preferred Stock was convertible, at the option of the holder or, upon the occurrence of certain events, at the option of the Issuer, and subject to certain conditions, into a number of shares of Common Stock determined by dividing the Accrued Value by the conversion price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":1678432},"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4125370,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":37890,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person received an additional 37,890 shares of Common Stock from the Issuer, representing the additional dividend accruals on the Redeemable Convertible Preferred Stock that the Reporting Person would have been entitled to receive up to and including March 31, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":3469029,"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4125369,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":1678432,"price":3.19,"value":5354198.08,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":3431139,"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4133794,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:58:46.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":47963,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000727","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000727/edgar.xml","form_type":"4"}},{"id":4133793,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":171195,"kind":"organization","name":"DP VI Associates, L.P.","position":1,"cik":"0001298034","reported_name":"DP VI Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:52:56.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":15731,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000725","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000725/edgar.xml","form_type":"4"}},{"id":4133792,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":171194,"kind":"organization","name":"Domain Partners VI, L.P.","position":1,"cik":"0001298033","reported_name":"Domain Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-12-13T16:42:31.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":20150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"At the effective time of the Merger, each warrant that was outstanding and unexercised immediately prior to the effective time of the Merger, with an exercise price less than $1.52, was cancelled and converted into the right of the holder of such warrant to receive, for each share of Common Stock underlying such warrant, (i) an amount in cash equal to the excess, if any, of $1.52 over the applicable exercise price for such share, and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the effective time of the Merger, each warrant that was outstanding and unexercised immediately prior to the effective time of the Merger, with an exercise price less than $1.52, was cancelled and converted into the right of the holder of such warrant to receive, for each share of Common Stock underlying such warrant, (i) an amount in cash equal to the excess, if any, of $1.52 over the applicable exercise price for such share, and (ii) one CVR."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":0.67,"exercise_date":"2013-07-15","expiration_date":"2019-10-01","underlying":"Common Stock","underlying_shares":20150},"source":{"system":"sec-edgar","filing":"0000904454-17-000722","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000722/edgar.xml","form_type":"4"}},{"id":4133791,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":171194,"kind":"organization","name":"Domain Partners VI, L.P.","position":1,"cik":"0001298033","reported_name":"Domain Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-12-13T16:42:31.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":20150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"At the effective time of the Merger, each warrant that was outstanding and unexercised immediately prior to the effective time of the Merger, with an exercise price less than $1.52, was cancelled and converted into the right of the holder of such warrant to receive, for each share of Common Stock underlying such warrant, (i) an amount in cash equal to the excess, if any, of $1.52 over the applicable exercise price for such share, and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the effective time of the Merger, each warrant that was outstanding and unexercised immediately prior to the effective time of the Merger, with an exercise price less than $1.52, was cancelled and converted into the right of the holder of such warrant to receive, for each share of Common Stock underlying such warrant, (i) an amount in cash equal to the excess, if any, of $1.52 over the applicable exercise price for such share, and (ii) one CVR."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":0.67,"exercise_date":"2013-07-15","expiration_date":"2019-03-30","underlying":"Common Stock","underlying_shares":20150},"source":{"system":"sec-edgar","filing":"0000904454-17-000722","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000722/edgar.xml","form_type":"4"}},{"id":4133790,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":171194,"kind":"organization","name":"Domain Partners VI, L.P.","position":1,"cik":"0001298033","reported_name":"Domain Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:42:31.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":1857036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000722","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000722/edgar.xml","form_type":"4"}},{"id":4133789,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:38:43.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":7333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000720/edgar.xml","form_type":"4"}},{"id":4133788,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:32:14.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":988285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000718","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000718/edgar.xml","form_type":"4"}},{"id":4229831,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-18T16:14:34.000Z","date":"2017-08-16","kind":"other","acquired":true,"shares":6477,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Susan W. and James C. Blair Family L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":9404,"source":{"system":"sec-edgar","filing":"0000904454-17-000580","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000580/edgar.xml","form_type":"4"}},{"id":4229830,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-18T16:14:34.000Z","date":"2017-08-16","kind":"other","acquired":true,"shares":4835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."}],"balance_after":7020,"source":{"system":"sec-edgar","filing":"0000904454-17-000580","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000580/edgar.xml","form_type":"4"}},{"id":4229829,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-18T16:14:34.000Z","date":"2017-08-16","kind":"other","acquired":false,"shares":92518,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By One Palmer Square Associates VII, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, LLC.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000580","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000580/edgar.xml","form_type":"4"}},{"id":4240488,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-08T16:03:14.000Z","date":"2017-08-04","kind":"sale","acquired":false,"shares":18450,"price":78.61,"value":1450354.5,"ownership":{"direct":false,"nature":"By DP VII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.19 to $79.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, LLC.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":17056,"source":{"system":"sec-edgar","filing":"0000904454-17-000551","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000551/edgar.xml","form_type":"4"}},{"id":4271939,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:24:52.000Z","date":"2017-06-23","kind":"other","acquired":true,"shares":2869,"ownership":{"direct":false,"nature":"By One Palmer Square Associates VII, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by Domain Partners VII, L.P. to its partners, including 2,869 shares to One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by Domain Partners VII, L.P. to its partners, including 2,869 shares to One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, VII, LLC.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":92518,"source":{"system":"sec-edgar","filing":"0000904454-17-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000469/edgar.xml","form_type":"4"}},{"id":4271938,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T16:24:52.000Z","date":"2017-06-23","kind":"other","acquired":false,"shares":286857,"ownership":{"direct":false,"nature":"By Domain Partners VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by Domain Partners VII, L.P. to its partners, including 2,869 shares to One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by Domain Partners VII, L.P. to its partners, including 2,869 shares to One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, VII, LLC.  Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0000904454-17-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000469/edgar.xml","form_type":"4"}},{"id":4285959,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-06-12T16:44:24.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over 12 months in equal monthly installments on each monthly anniversary of the date of grant, beginning on 07/08/2017 and ending on 06/08/2018."}],"balance_after":10000,"derivative":{"exercise_price":59.56,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000904454-17-000442","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000442/edgar.xml","form_type":"4"}},{"id":4308650,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T16:47:54.000Z","date":"2015-07-16","kind":"other","acquired":true,"shares":2927,"ownership":{"direct":false,"nature":"By Susan W. and James C. Blair Family L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.  This amendment is being filed solely to report the acquisition of shares of Common Stock by this entity on 07/16/2015, which was inadvertently omitted from the Form 4 filed on 07/17/2015."}],"balance_after":2927,"source":{"system":"sec-edgar","filing":"0000904454-17-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000394/edgar.xml","form_type":"4/A","original_submission_date":"2015-07-17"}},{"id":4308649,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T16:47:54.000Z","date":"2015-07-16","kind":"other","acquired":true,"shares":2185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As a managing member of the sole general partner of Domain Partners VII, L.P., the Reporting Person may be deemed to indirectly beneficially own 2,081,745 shares of Common Stock held by Domain Partners VII, L.P."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"As a managing member of the sole general partner of DP VII Associates, L.P., the Reporting Person may also be deemed to indirectly beneficially own 35,506 shares of Common Stock held by  DP VII Associates, L.P."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"As a managing member of Domain Associates, LLC, the Reporting Person may also be deemed to indirectly beneficially own 32,760 shares of Common Stock held by Domain Associates, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VII, L.P., DP VII Associates, L.P., One Palmer Square  Associates VII, LLC and Domain Associates, LLC , however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2185,"source":{"system":"sec-edgar","filing":"0000904454-17-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000394/edgar.xml","form_type":"4/A","original_submission_date":"2015-07-17"}},{"id":4308648,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T16:47:54.000Z","date":"2015-07-16","kind":"other","acquired":false,"shares":41813,"ownership":{"direct":false,"nature":"By One Palmer Square Associates VII, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares in kind by One Palmer Square Associates VII, LLC to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As a managing member of One Palmer Square  Associates VII, LLC, the Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by One Palmer Square Associates VII, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000394/edgar.xml","form_type":"4/A","original_submission_date":"2015-07-17"}},{"id":4325413,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":1,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-11T16:14:13.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the one-year anniversary of the date of grant or the Issuer's 2018 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":3.15,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000904454-17-000341","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024000/000090445417000341/edgar.xml","form_type":"4"}},{"id":4353903,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-04-12T18:04:59.000Z","date":"2017-04-11","kind":"purchase","acquired":true,"shares":368,"price":100,"value":36800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As managing members of the sole general partner of Domain Partners VIII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VIII, L.P., as reported on a Form 4 for Domain Partners VIII, L.P. filed on the same date as this Form 4."}],"balance_after":368,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":11536},"source":{"system":"sec-edgar","filing":"0000904454-17-000306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000306/edgar.xml","form_type":"4"}},{"id":4354080,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-04-12T17:49:49.000Z","date":"2017-04-11","kind":"purchase","acquired":true,"shares":49632,"price":100,"value":4963200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As managing members of the sole general partner of DP VIII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VIII Associates, L.P., as reported on a Form 4 for DP VIII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":49632,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":1555862},"source":{"system":"sec-edgar","filing":"0000904454-17-000304","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000304/edgar.xml","form_type":"4"}},{"id":4566961,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":17695,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":8.19,"underlying":"Common Stock","underlying_shares":17695},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566960,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":1071,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":42.93,"underlying":"Common Stock","underlying_shares":1071},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566959,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":1996,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":36,"underlying":"Common Stock","underlying_shares":1996},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566958,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":38094,"price":28.35,"value":1079964.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly benefically owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person.  Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4568481,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":171195,"kind":"organization","name":"DP VI Associates, L.P.","position":1,"cik":"0001298034","reported_name":"DP VI Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:54:34.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":1657,"price":28.35,"value":46975.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001533","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001533/edgar.xml","form_type":"4"}},{"id":4568480,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:47:55.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":3553322,"price":28.35,"value":100736678.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001531","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001531/edgar.xml","form_type":"4"}},{"id":4568479,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:45:15.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":47613,"price":28.35,"value":1349828.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001529","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001529/edgar.xml","form_type":"4"}},{"id":4568478,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":171194,"kind":"organization","name":"Domain Partners VI, L.P.","position":1,"cik":"0001298033","reported_name":"Domain Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:42:39.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":285679,"price":28.35,"value":8098999.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001527","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001527/edgar.xml","form_type":"4"}},{"id":4579795,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":14271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14271},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579794,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":20583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20583},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579793,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":11083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14716},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579792,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":49570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":49570,"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579791,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":482326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":482326},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579790,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":597207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":597207},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579789,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":836722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":836722},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579788,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":1206836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1206836},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579787,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":649835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":862879},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579786,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":3985970,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":3985970,"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4604771,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":171194,"kind":"organization","name":"Domain Partners VI, L.P.","position":1,"cik":"0001298033","reported_name":"Domain Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-13T16:27:30.000Z","date":"2016-09-09","kind":"other","acquired":false,"shares":1943109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares in kind by Domain Partners VI, L.P. to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the sole general partner of Domain Partners VI, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VI, L.P., however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein, and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001441","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001441/edgar.xml","form_type":"4"}}]}